Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)
China · Delayed Price · Currency is CNY 26.52
-0.07 (-0.26%)
Aug 15, 2025, 3:00 PM CST
SHA:600566 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 2,127 | 2,532 | 2,823 | 2,171 | 1,719 | 1,277 | Upgrade |
Depreciation & Amortization | 302.41 | 302.41 | 302.68 | 308.8 | 293.81 | 280.95 | Upgrade |
Other Amortization | 6.84 | 6.84 | 2.04 | 9.49 | 10.25 | 7.12 | Upgrade |
Loss (Gain) From Sale of Assets | -0.2 | -0.2 | -0.13 | -5.22 | -0.65 | -3.35 | Upgrade |
Asset Writedown & Restructuring Costs | 0.28 | 0.28 | 1.09 | 0.53 | 0.42 | 0.77 | Upgrade |
Loss (Gain) From Sale of Investments | -182.74 | -182.74 | -96.33 | -58.89 | -161.53 | -22.31 | Upgrade |
Provision & Write-off of Bad Debts | -22.16 | -22.16 | -3.04 | 36.02 | 8.28 | 6.23 | Upgrade |
Other Operating Activities | -104.75 | 35.21 | 21.68 | 31.75 | 32.77 | 33.05 | Upgrade |
Change in Accounts Receivable | 253.56 | 253.56 | 22.81 | -713.7 | -181.19 | 15.25 | Upgrade |
Change in Inventory | -81.9 | -81.9 | -98.6 | -15.89 | -97.17 | 60.05 | Upgrade |
Change in Accounts Payable | -698.68 | -698.68 | 476.51 | 856.54 | 269.44 | 89.94 | Upgrade |
Change in Other Net Operating Assets | 10.09 | 10.09 | 8.52 | -4.07 | -6.24 | 31.16 | Upgrade |
Operating Cash Flow | 1,632 | 2,176 | 3,464 | 2,621 | 1,894 | 1,782 | Upgrade |
Operating Cash Flow Growth | -53.40% | -37.17% | 32.17% | 38.35% | 6.32% | -17.04% | Upgrade |
Capital Expenditures | -113.54 | -174.34 | -301.64 | -243.66 | -248.32 | -429.63 | Upgrade |
Sale of Property, Plant & Equipment | 0.73 | 0.69 | 7.98 | 52.82 | 0.79 | 1.54 | Upgrade |
Divestitures | - | - | - | - | - | 35.5 | Upgrade |
Investment in Securities | -3,698 | -1,951 | -182.68 | -1,380 | -474.89 | -1,096 | Upgrade |
Other Investing Activities | 97.82 | 84.81 | 82.12 | 67.53 | 49.11 | 7.6 | Upgrade |
Investing Cash Flow | -3,713 | -2,040 | -394.23 | -1,503 | -673.3 | -1,481 | Upgrade |
Short-Term Debt Issued | - | 1,442 | 1,095 | 400 | - | - | Upgrade |
Total Debt Issued | 1,058 | 1,442 | 1,095 | 400 | - | - | Upgrade |
Short-Term Debt Repaid | - | -1,406 | -400 | -7.52 | -0 | - | Upgrade |
Long-Term Debt Repaid | - | -1.4 | -1.48 | -1.79 | -1.82 | -0 | Upgrade |
Total Debt Repaid | -1,724 | -1,407 | -401.48 | -9.31 | -1.82 | -0 | Upgrade |
Net Debt Issued (Repaid) | -666.48 | 34.71 | 693.96 | 390.69 | -1.82 | -0 | Upgrade |
Issuance of Common Stock | - | - | 14.21 | 97.18 | 50 | 1,405 | Upgrade |
Repurchase of Common Stock | -22.18 | -22.18 | -35.67 | - | - | - | Upgrade |
Common Dividends Paid | -1,213 | -1,218 | -823.19 | -605.45 | -409.37 | -1,009 | Upgrade |
Other Financing Activities | 5.73 | - | - | - | - | -22.41 | Upgrade |
Financing Cash Flow | -1,896 | -1,205 | -150.69 | -117.58 | -361.19 | 373.8 | Upgrade |
Net Cash Flow | -3,977 | -1,069 | 2,919 | 999.94 | 859.84 | 674.34 | Upgrade |
Free Cash Flow | 1,518 | 2,002 | 3,162 | 2,377 | 1,646 | 1,352 | Upgrade |
Free Cash Flow Growth | -52.09% | -36.69% | 33.03% | 44.42% | 21.74% | -15.56% | Upgrade |
Free Cash Flow Margin | 21.26% | 24.97% | 32.76% | 26.42% | 21.57% | 21.93% | Upgrade |
Free Cash Flow Per Share | 1.66 | 2.18 | 3.45 | 2.62 | 1.83 | 1.62 | Upgrade |
Cash Income Tax Paid | 1,331 | 1,464 | 1,650 | 1,264 | 1,177 | 926.3 | Upgrade |
Levered Free Cash Flow | 1,123 | 1,296 | 2,278 | 1,640 | 1,012 | 908.93 | Upgrade |
Unlevered Free Cash Flow | 1,138 | 1,313 | 2,289 | 1,659 | 1,034 | 929.58 | Upgrade |
Change in Working Capital | -494.75 | -494.75 | 413.18 | 127.6 | -8.19 | 202.02 | Upgrade |
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.